Tip 134: MCAD

MCAD (medium chain acyl-CoA dehydrogenase) deficiency is the most common fatty oxidation defect and is inherited in an autosomal recessive fashion.

It became part of the UK newborn screening programme in 2009.

The deficient enzyme is part of the β-oxidation pathway, which is essential at times of fasting stress, thus the need for increased carbohydrate intake or IV dextrose during episodes of illness. Presentation of metabolic decompensation includes hypoketotic hypoglycaemia with lethargy and seizures.

Reference: Dyack, S, Expanded newborn screening: Lessons learned from MCAD deficiency, Paediatr Child Health. Apr 2004; 9(4): 241–243.

Previously published: 02/07/14, 19/06/15

This entry was posted in Metabolic, Screening. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.